Health
Amylyx avexitide cuts hypoglycemic events 55%
Amylyx Pharmaceuticals (NASDAQ:AMLX) said avexitide met the Phase 3 LUCIDITY primary endpoint with a 55% reduction in Level 2 and Level 3 hypoglycemic events versus placebo.
Brie Carter
TV Presenter & Finance EditorTV presenter and finance editor at Grafa, with a Master’s in Commerce from UWA and diverse industry experience in finance, insurance, and media.
Contact
Contact editorial teamArticles by Brie Carter
Retail
Amer Sports revenue increases 32% to $1.63 billion
Amer Sports (NYSE:AS) reported a 32% increase in second-quarter revenue to $1,633 million across its global operations.
Technology
Baidu Q2 revenue drops 4% to RMB31.3 billion
Baidu (NASDAQ:BIDU) reported Q2 2026 revenue of RMB31.3 billion, down 4% year over year and 2% sequentially.
Cryptocurrency
Circle’s EURC tops €400M supply
Circle’s EURC (CRYPTO:EURC) has surpassed €400 million in circulation after more than doubling over the past year.
Energy
Ecopetrol completes $1.2 billion Brava control deal
Offshore and onshore Brazilian oil production infrastructure representing Ecopetrol’s US$1.2 billion acquisition of a controlling stake in Brava Energia.
Cryptocurrency
Solana whale buys $3.6M in SOL
A dormant Solana (CRYPTO:SOL) whale bought 47,535 SOL worth about $3.6 million after nearly two years.
Cryptocurrency
Whale stakes $61.48M in Ethereum
An anonymous whale deposited 32,400 Ether worth about $61.48 million into Ethereum’s staking contract.
Lifestyle
Cogstate reports FY26 revenue of US$60.9M
Cogstate (ASX:CGS) announced its financial results for the year ended June 30, delivering group revenue of US$60.9 million.
Investment
Truth Ventures urges new test for seed startups
Truth Ventures CEO Varun Datta says seed crypto startups should not be judged by recurring revenue.
Technology
Payward joins AI security project with Mythos 5
Payward, the parent company of Kraken, has joined Project Glasswing and gained access to Claude Mythos 5.